Equity · Healthcare
BLCO
Bausch + Lomb Corporation · NYSE
The line runs $15.25 on 10 June through $18 on 4 September, on a scale from $14 to $20. Days the market did not trade hold the previous close, flat.
The chart above plots the price of BLCO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $15.25 on 10 June 2026 through $18 on 4 September 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 7, 2026
BLCO insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
BLCO reported financials
BLCO reported revenue of $5.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$360.0M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
BLCO earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
BLCO institutional holders
14 of the 45 institutional funds we track reported a BLCO position for the quarter ended 30 Jun 2026 — a combined $238.4M; the latest of those filings landed 02 Sep 2026.
Showing the 10 largest of 14 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
BLCO fails-to-deliver
On 12 Aug 2026, 98 shares of BLCO failed to deliver (about $2K) — the latest of 3 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data